Global Health Limited has submitted a regulatory intimation to both BSE Limited and the National Stock Exchange of India Limited regarding a scheduled meeting with investors/analysts.
The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
- Date of Meeting: November 23, 2026
- Investor/Analyst Firm: ICM Utilico
- Type of Meeting: One to One
- Place of Meeting: Gurugram
- Mode of Meeting: In person
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during this meeting.
Important Note
The disclosure includes a note that the meeting is subject to change in case of any unforeseen circumstances on the part of the analysts, investors, or the company.
The document was digitally signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), on November 18, 2026, at 15:50:11 IST.